Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies.

导出 OA

翻译打印收藏纠错

作者： Mikako,Ito ^[1] ; Tohru,Ibi ^[2] ; Ko,Sahashi ^[3] ; Masashi,Ichihara ^[4] ; Masafumi,Ito ^[5] ; Kinji,Ohno ^[1]

作者单位： Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan. ^[1] Faculty of Pathophysiology and Therapeutics, Aichi Medical University College of Nursing, 21 Karimata Yazako, Nagakute-cho, Aichi-gun, Aichi 480-1195, Japan. ^[2] Department of Neurology, Aichi Medical University School of Medicine, 21 Karimata Yazako, Nagakute-cho, Aichi-gun, Aichi 480-1195, Japan. ^[3] Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, 1200 Matsumoto, Kasugai, Aichi 487-8501, Japan. ^[4] Department of Longevity and Aging Research, Gifu International Institute of Biotechnology, 1-1 Nakafudogaoka, Kakamigahara, Gifu 504-0838, Japan. ^[5]

DOI 10.1186/2045-9912-1-24

PMID 22146674

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览36

Medical gas research

2011年1卷1期

24页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies.

Medical gas research

相似文献

Medical gas research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies.

Medical gas research

相似文献

Medical gas research

相关期刊

检索历史清除